The treatments available for Alzheimer’s disease are most effective in the early stages, when it is still asymptomatic. That is why an early diagnosi1
The Translational research programme for brain disorders was created to add to our knowledge of the biological foundations and factors that predispos1
The creation of the Clínic Barcelona Comprehensive Cancer Center represents a step forward in the integration of care, clinical research, translation1
HUB Alzheimer Barcelona is a pioneering collaborative initiative rooted in a commitment to transform the future of research and provide support for p1
These findings offer a solid basis for designing clinical trials of therapies aimed at modifying the development of these neurodegenerative diseases1
The study aims to better understand the biological processes that are altered differently in men and women in the early stages of Alzheimer's disease1
Researchers at the Clínic-IDIBAPS led a study published in the Alzheimer’s & Dementia journal on the relationship between the integrity of the locus1
This year, FERO will contribute €200,000, with which it will seek to provide structural and sustained support for the Molecular Diagnostics Programme1
The centre becomes the first in Spain to use blood biomarker p-tau217, which offers a more accurate and less invasive diagnosis and marks a paradigm1
The Minister and the Director of CERCA met with the management of the centre and visited IDIBAPS' facilities.
